Overview
An SGLT2 inhibitor for type 2 diabetes and cardio-renal risk reduction.
Specifications
| CAS | 864070-44-0 |
| Standard | USP |
| Category | API |
| Regulatory files | Available on request |
| Therapeutic area | Metabolic & Diabetes |
Regulatory support
Available under NDA for qualified products.
Safety Data Sheet (SDS) & CoA
An SDS and a representative CoA are available for every catalogue product. For your compliance or qualification file, request them by email or the RFQ form — our team releases them together with the documentation package you need.
Request the SDS & CoA by emailRequest documentation & quotation
Specify your target market and annual volume; we'll reply with the relevant dossier and price.
Ask for the dossier
GMPUS FDA inspectedUSP